Meet Assura: Our Net Cost Guarantee Pricing Solution

The cost of specialty medications continues to rise. With a growing pipeline of specialty drugs and newer therapies costing in excess of $100,000 for a single course of treatment, a handful of claims can significantly impact a plan’s financial performance and stability. At the same time, utilization of specialty drugs, particularly those treating cancer and autoimmune conditions, is also increasing. In this climate, plans need a new approach and a PBM partner that is fully aligned with their goals and invested in helping them navigate this complex and uncertain environment.
OUR JOURNEY

A different kind of PBM

If your PBM is going to continue to take spread, chase rebates, and drive utilization to higher drug prices, maybe it’s time to consider a different kind of PBM.

Contact Us